Is there any foreign generic drug and price reference for Lurbinectedin?

Lurbinectedin (Lurbinectedin) is currently on the market in several regions as an original drug, but there are no generic drugs on the market overseas. In China, the original drug Rubicatin has been approved and entered the market. However, due to differences in launch time and channels, its domestic retail price has not yet formed unified public data. Patients must refer to the actual selling price published by local hospital pharmacies or pharmaceutical companies. If you are considering taking medication, it is recommended to first confirm the indications and medication plan with the attending physician, and then consult the hospital pharmacy or authorized distribution channels to obtain accurate prices and drug purchasing guidelines.

In overseas markets, the price of Rubicatin’s original drug varies significantly and is greatly affected by exchange rates and channels. According to market information, the price of the original research version (4 mg/box) sold in Hong Kong may be more than 20,000 yuan (specifically, it is subject to the price quoted by the local pharmacy and fluctuates with the exchange rate); the price of the American version is relatively higher, equivalent to about more than 90,000 yuan; the price of the Singapore version is about more than 30,000 yuan. These prices are reference ranges. Additional costs such as taxes, transportation, customs clearance and agency service fees must also be considered when actually purchasing drugs, so the total cost may be higher.

Currently, there are no generic drugs of Rubicatin available overseas, which means that if it cannot be obtained in time in China or the price poses a great burden to patients, it will be difficult to significantly reduce costs through legal generic drug channels in the short term. Patients who are considering cross-border drug purchase should be extremely cautious: give priority to regular hospitals or authorized pharmacies, and reliable international drug agencies, confirm the approval number, batch and authenticity certificate of the drug, and avoid purchasing drugs privately or through informal channels to prevent counterfeit drugs or quality problems. At the same time, be sure to comply with the customs and drug import regulations of the country and region where you are located to avoid illegal risks.

Finally, regarding payment and reimbursement: Rubicatin is already on the market in China, but whether it is included in medical insurance and the reimbursement ratio vary by region. Patients should consult local medical insurance agencies or hospital medical insurance offices for specific policies and procedures before making decisions. Regardless of whether you choose domestic purchasing or overseas channels, it is recommended to comprehensively evaluate the expected efficacy, affordability, and medication safety with the assistance of the attending doctor, pharmacist, and hospital finance/span>/medical insurance department, and formulate a sustainable treatment and follow-up plan to ensure that the medication is in compliance with medical standards and protects the rights of patients.

Reference materials:https://www.drugs.com/